esketamine
Commercial- Indications
- Treatment-resistant Depression
Company intelligence / Profile preview
Mindful Health Solutions delivers advanced interventional psychiatric treatments—including Transcranial Magnetic Stimulation, Esketamine nasal spray, IV Ketamine therapy—and comprehensive behavioral health services to patients with treatment-resistant depression and related conditions. The company has treated over 100,000 patients with more than 300,000 interventional treatments delivered. It maintains one of the largest real-world outcome repositories in this field (>50k patients), using this data to refine patient care pathways and develop predictive algorithms for optimal treatment selection. MHS was among the first U.S. clinics to scale both TMS and Esketamine therapies.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mindful Health Solutions.